National Institute of Mental Health (NIMH): Bipolar Disorder trials
The registry lists 38 Bipolar Disorder studies with National Institute of Mental Health (NIMH) as lead sponsor. 3 are open to participants now and 4 have results posted.
Phase 2 15Phase 3 2Phase 4 1No phase 20(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Natural History of Depression, Bipolar Disorder and Suicide RiskRecruitingNCT06462196
- NIMH Rhythms and Blues Study: A Prospective Natural History Study of Motor Activity, Mood States, and Bipolar DisorderRecruitingNCT05669703
- Evaluation of Patients With Mood and Anxiety Disorders and Healthy VolunteersRecruitingNCT00024635
- Double-Blind Placebo-Controlled Trial of Riluzole in Pediatric Bipolar DisorderTerminatedNCT00805493Phase 2Results posted
- Effectiveness of Lithium Plus Optimized Medication in Treating People With Bipolar DisorderCompletedNCT00667745Phase 4Results posted
- The Antidepressant Efficacy of the Anticholinergic ScopolamineTerminatedNCT00369915Phase 2Results posted
- Riluzole to Treat Depression in Bipolar DisorderTerminatedNCT00054704Phase 2Results posted
- Transcranial Electric Stimulation Therapy (TEST) for Treatment Resistant Depression (TRD)Active, not recruitingNCT05172271Not applicable
- Mental Health Impact of the COVID-19 Pandemic on Amish and Mennonite Participants in AMBiGenCompletedNCT04684615
- Procedures for Sample Acquisition and Distribution for The Human Brain Collection CoreTerminatedNCT03092687
- Identifying Predictors of Bipolar Disorder Relapse During Pregnancy and the Postpartum PeriodWithdrawnNCT00720395
- A Glutamate Transporter GLT1, in the Treatment of Bipolar DisorderWithdrawnNCT00512616Phase 2
- Mitochondrial Dysfunction in the Pathophysiology and Treatment of Bipolar DisorderWithdrawnNCT00327756Phase 2
- Dopamine Receptor Imaging in Mood DisordersCompletedNCT00116077
- Cholinergic Modulation of Condition and Emotion in Mood Disorders: Functional Neuroimaging StudiesTerminatedNCT00055575Phase 2
- Brain Imaging in DepressionCompletedNCT00050700
- Clinical Trial of Mifepristone for Bipolar DepressionCompletedNCT00043654Phase 2
- Clozapine vs. Placebo in Treatment-Refractory Bipolar Disorder in Children and AdolescentsCompletedNCT00036582Phase 3
- Clinical Trial of Felbamate for Treatment-Resistant Bipolar DepressionCompletedNCT00034229Phase 2
- The Treatment of Children and Adolescents With Treatment-Resistant DepressionCompletedNCT00029640
- Clozapine for Treatment-Resistant ManiaCompletedNCT00029458Phase 2
- Examination of Brain Serotonin Receptors in Patients With Mood DisordersCompletedNCT00026832
- Examination of Tamoxifen in Acute Mania in Patients With Bipolar I DisorderCompletedNCT00026585Phase 2
- Clinical Trial of Pramipexole in Bipolar DepressionCompletedNCT00025792Phase 2
- Pilot Study of Levetiracetam (Keppra® (Registered Trademark)) for Bipolar IllnessCompletedNCT00015769Phase 2
- Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD)CompletedNCT00012558Not applicable
- Child & Adolescent Bipolar Disorder Brain Imaging and Treatment StudyCompletedNCT00006177
- Treatment of Depression in Youth With Bipolar DisordersTerminatedNCT00005015Phase 3
- Evaluation of Patients With Rapid Cycling Bipolar Disorder (RCBD)CompletedNCT00001772
- The Evaluation and Follow-up of Patients With Bipolar DisorderCompletedNCT00001652
- Evaluation of Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of Mood DisordersCompletedNCT00001545Phase 2
- Genetic Aspects of Neurologic and Psychiatric DisordersCompletedNCT00001544
- Acute Effectiveness of Additional Drugs to the Standard Treatment of DepressionCompletedNCT00001483Phase 2
- Effects of Sex Hormones on Circadian Rhythm in Men and WomenCompletedNCT00001285
- Brain Tissue Collection for Neuropathological StudiesTerminatedNCT00001260
- Evaluation of the Genetics of Bipolar DisorderCompletedNCT00001174
- Study of the Psychological Development of Children of Parents With and Without Affective DisordersCompletedNCT00001170
- Omega-3 Fatty Acids in the Treatment of Bipolar Disorder: A Double-Blind, Placebo-Controlled TrialCompletedNCT00001146Phase 2